MetaCap

Capstone (CAPS) vs Onconetix (ONCO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Capstone is the larger company by market cap ($3.7 million vs $3.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAPS+0.57%ONCO+9.56%
+10%+5%-0%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAPS versus ONCO key metrics
MetricCAPSONCO
Share price$0.1409$0.6543
Market cap$3.72M$3.43M
1-day change+0.57%+9.56%
P/E ratio (TTM)—0.00
EPS (TTM)$-3.32$310.39
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.36$207.00
52-week low$0.13$0.58
Distance from 52-week high-89.64%-99.68%
Analyst consensusnone—
Avg. price target upside+2029.17%—
Average volume4.35M2.96M
Shares outstanding26.38M5.24M
Employees932
SectorBasic MaterialsHealthcare
IndustryBuilding MaterialsBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: Capstone in Basic Materials and Onconetix in Healthcare.

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Basic Materials · Building Materials · 93 employees

About Onconetix

ONCO stock →

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Healthcare · Biotechnology · 2 employees

CAPS vs ONCO FAQ

Which is bigger, Capstone or Onconetix?

Capstone (CAPS) is larger, with a market capitalization of $3.72M compared with $3.43M for Onconetix (ONCO).

Are Capstone and Onconetix in the same industry?

No. Capstone is in the Basic Materials sector, while Onconetix is in Healthcare.

More comparisons